FDA Strengthens Warnings of Severe Kidney Injuries Caused by Diabetes Medication Invokana
The Food and Drug Administration just issued another Drug Safety Communication alerting doctors and patients about serious health risks associated with several type 2 diabetes medications, including Invokana. The FDA is strengthening warnings about the risk of serious, acute kidney injuries for patients taking type 2 diabetes medications canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo …
